• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 bulk 到单细胞视角全面分析卵巢癌的共识分子亚型。

Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives.

机构信息

College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.

Department of Gynecology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

J Biol Chem. 2024 Sep;300(9):107710. doi: 10.1016/j.jbc.2024.107710. Epub 2024 Aug 22.

DOI:10.1016/j.jbc.2024.107710
PMID:39178946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11418113/
Abstract

Molecular subtypes play a pivotal role in guiding preclinical and clinical risk assessment and treatment strategies in cancer. In this study, we extracted whole-tissue transcriptomic data from 1987 ovarian cancer patients spanning 26 independent Gene Expression Omnibus cohorts. A total of four consensus subtypes (C1-C4) were identified, notably, subtype C1 samples exhibited a poor prognosis and higher M2 macrophages infiltration, whereas subtype C2 samples demonstrated the best prognosis and higher CD4 resting T cells infiltration. Additionally, we characterized cancer- and stromal-specific gene expression profiles, and conducted an analysis of ligand-receptor interactions within these compartments. Based on cancer compartment, subtype-specific interactions as well as gene signatures for each molecular subtype were identified. Leveraging single-cell transcriptomic data, we delineated malignant epithelial cells with four molecular subtypes and observed an increase in C1 cell proportions from primary to relapse to metastasis stages, with a corresponding decrease in C2 cell proportions. Furthermore, we investigated subtype-specific interaction with T cells through integrated analysis of bulk and single-cell datasets. Finally, we developed a robust ten-gene risk model based on subtype gene signatures for prognostic evaluation in ovarian cancer, demonstrating its efficacy across independent datasets. In summary, this study systematically explored ovarian cancer molecular subtypes and provided a framework for other cancer types.

摘要

分子亚型在指导癌症的临床前和临床风险评估以及治疗策略方面发挥着关键作用。在这项研究中,我们从跨越 26 个独立基因表达综合数据集的 1987 名卵巢癌患者中提取了全组织转录组数据。总共确定了四个共识亚型(C1-C4),值得注意的是,亚型 C1 样本表现出较差的预后和更高的 M2 巨噬细胞浸润,而亚型 C2 样本则表现出最佳的预后和更高的 CD4 静止 T 细胞浸润。此外,我们还对肿瘤和基质特异性基因表达谱进行了特征分析,并对这些部位的配体-受体相互作用进行了分析。基于肿瘤区室,确定了亚型特异性相互作用以及每个分子亚型的基因特征。利用单细胞转录组数据,我们描绘了具有四个分子亚型的恶性上皮细胞,并观察到从原发性到复发再到转移阶段 C1 细胞比例增加,C2 细胞比例相应降低。此外,我们通过对批量和单细胞数据集的综合分析研究了与 T 细胞的特定亚型相互作用。最后,我们基于亚型基因特征开发了一种稳健的十基因风险模型,用于卵巢癌的预后评估,在独立数据集上证明了其有效性。总之,本研究系统地探讨了卵巢癌的分子亚型,并为其他癌症类型提供了一个框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/3e56a4801313/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/4ba6011711a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/1d55018265f7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/fbd5d4592fc6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/13ca956b027f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/cb25332d377f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/3cfc787173f7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/9f7b37ba4185/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/3ab1feccac9d/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/56b5b0883eb2/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/282efba905f9/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/4e4d62161917/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/3e56a4801313/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/4ba6011711a9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/1d55018265f7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/fbd5d4592fc6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/13ca956b027f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/cb25332d377f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/3cfc787173f7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/9f7b37ba4185/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/3ab1feccac9d/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/56b5b0883eb2/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/282efba905f9/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/4e4d62161917/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95fa/11418113/3e56a4801313/figs6.jpg

相似文献

1
Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives.从 bulk 到单细胞视角全面分析卵巢癌的共识分子亚型。
J Biol Chem. 2024 Sep;300(9):107710. doi: 10.1016/j.jbc.2024.107710. Epub 2024 Aug 22.
2
High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.单细胞 RNA 测序细化的高级别浆液性卵巢癌:特定细胞亚型影响生存并决定分子亚型分类。
Genome Med. 2021 Jul 9;13(1):111. doi: 10.1186/s13073-021-00922-x.
3
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer.基质混合对浆液性卵巢癌分子亚型和预后基因特征的影响。
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):509-519. doi: 10.1158/1055-9965.EPI-18-1359. Epub 2019 Dec 23.
4
Comprehensive profiling of endocrine metabolism identifies a novel signature with robust predictive value in ovarian cancer.全面分析内分泌代谢组学鉴定出卵巢癌中具有稳健预测价值的新型标志物。
J Gene Med. 2024 May;26(5):e3686. doi: 10.1002/jgm.3686.
5
Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.单细胞 RNA 测序揭示恶性上皮细胞中的 MYBL2 参与卵巢癌的发生和发展。
Front Immunol. 2024 Jul 29;15:1438198. doi: 10.3389/fimmu.2024.1438198. eCollection 2024.
6
Identification of metabolism-associated molecular subtype in ovarian cancer.卵巢癌代谢相关分子亚型的鉴定。
J Cell Mol Med. 2021 Oct;25(20):9617-9626. doi: 10.1111/jcmm.16907. Epub 2021 Sep 15.
7
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.结肠癌的基因表达分类为分子亚型:特征描述、验证和预后价值。
PLoS Med. 2013;10(5):e1001453. doi: 10.1371/journal.pmed.1001453. Epub 2013 May 21.
8
Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis.卵巢癌免疫转录组综合分析鉴定出具有抗肿瘤免疫活性表型和良好预后的四趋化因子主导亚型。
Br J Cancer. 2024 Oct;131(6):1068-1079. doi: 10.1038/s41416-024-02803-7. Epub 2024 Aug 2.
9
Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.鉴定预测卵巢癌患者预后的免疫微环境亚型。
J Cell Mol Med. 2021 Apr;25(8):4053-4061. doi: 10.1111/jcmm.16374. Epub 2021 Mar 6.
10
UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.UGDH 促进卵巢癌中的肿瘤起始细胞和纤维炎性肿瘤微环境。
J Exp Clin Cancer Res. 2023 Oct 19;42(1):270. doi: 10.1186/s13046-023-02820-z.